Esperion Therapeutics licensed products to HLS Therapeutics Inc. for commercialization in the Canadian market.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Esperion Therapeutics licensed products to HLS Therapeutics Inc. for commercialization in the Canadian market.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Esperion Therapeutics
American pharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- CNW GroupHLS Therapeutics Announces Q2 2025 Financial Results Adjusted EBITDA grew 21% in Q2 and 29% year-to-date Cash from operations grew 83% in Q2 and 147% year-to-date Made principal repayments on the Com